Helsinki Heart Study. New perspectives in the prevention of coronary heart disease.

Abstract

The Helsinki Heart Study tested the effect of modifying plasma low density lipoprotein (LDL)- and high density lipoprotein (HDL)-cholesterol on the primary prevention of coronary heart disease in middle-aged men with non-HDL-cholesterol greater than or equal to 5.2 mmol/L (200 mg/dl). One group (2046 men) received 600mg of gemfibrozil twice daily, and the… (More)

Topics

Cite this paper

@article{Huttunen1988HelsinkiHS, title={Helsinki Heart Study. New perspectives in the prevention of coronary heart disease.}, author={Jussi K. Huttunen and Maximilian Frick and Olle G Heinonen and P Heinsalmi and Vesa Manninen and Matti M{\"a}ntt{\"a}ri and M{\'o}nica Romo}, journal={Drugs}, year={1988}, volume={36 Suppl 3}, pages={32-6} }